Friday, 14 May 2021 / Nancy Crotti / Medical Design and Outsourcing OncoRes Medical’s system may detect cancer cells on a microscopic scale during a lumpectomy, potentially averting the need for a second breast cancer surgery. Combining optical coherence tomography imaging (OCT; left) with micro-elastography technologies, OncoRes’ quantitative micro-elastography (QME) imaging system provides real-time tumor assessment that helps surgeons more accurately identify and remov

Monday, 3 May 2021 OncoRes Medical has received ‘Breakthrough Device Designation’ from the U.S. Food and Drug Administration (FDA) to...

Tuesday, 9 March 2021 / Australian Investment Council In the second part of the Invest Week digital series, Yasser is joined by Dr Kath...

Friday, 22 January 2021 OncoRes team (L-R): Ruedi Hauri, Cosimo Santella and Teddy Yeo Innovation and ICT Minister Dave Kelly today...

Thursday, 29 October 2020 Perth-based medtech company, OncoRes Medical, has taken out the IGNITE Madness pitch competition in Houston,...

Wednesday, 29 July 2020 / Charles Gunningham / Startup News Perth-based medtech OncoRes Medical has been awarded $1 million funding as part of the Australian Government’s Medical Research Future Fund BioMedTech Horizons program, operated by MTPConnect. Image: Dr Kath Giles, CEO of OncoRes Medical Excerpt from article: Kath Giles’ medtech company OncoRes Medical , which famously won the global Pitch@Palace competition 18 months ago, has been awarded a $1M federal governm

Monday, 20 July 2020 Perth-based medtech company, OncoRes Medical, has been awarded $1 million funding as part of the Australian...

Wednesday, 15 April 2020 Abstract Inadequate margins in breast-conserving surgery (BCS) are associated with an increased likelihood of...

Thursday, 31 October 2019 / AusBiotech Kath Giles and Dr Christobel Saunders (centre) Winners of Emerging Company of the Year Inaugural AusBiotech Life Sciences Legacy Award: Mr Chuck Feeney AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards Industry Leadership Award: Sue MacLeman Company of the Year: PolyNovo Emerging Company of the Year: OncoRes Medical Emerging Company of the Year: OncoRes Medical OncoRes Medical, led by Dr Kath Giles, CEO and Managin

Wednesday, 30 October 2019 / By Colin Miller / MedTech Strategist The treatment of breast cancer today commonly entails repeat breast conserving surgeries due to imprecise methods of locating and measuring tumors during surgery. These lead to unnecessary expenditures of over $1 billion across the US and Europe. To help surgeons reduce these follow-up surgeries, OncoRes Medical is developing a probe that detects residual tumor within the surgical cavity in real time using

Monday, 28 October 2019 / Tech23 Image: Dr Kath Giles, CEO of OncoRes Medical Except from article: We’re still buzzing from Australia’s national celebration of deeptech innovation that was held in Sydney last week on Wednesday 23 October! Companies from across the nation shared how they are tackling big challenges with quantum computing, next generation robots, clever climate change solutions, inspiring healthtech and so much more. This article was first published by Tech23

Friday, 28 June 2019 / Stephanie Palmer-Derrien / Smart Company OncoRes Chief Executive Katherine Giles with Co-Founders Brendan Kennedy and Christobel Saunders. Souce: Supplied. Excerpt from article: Medtech startup OncoRes has been selected to take part in the prestigious MedTech Innovator Accelerator program in the US, becoming the first ever Aussie company in the final 24 and making waves within the first few weeks. The startup beat some 818 applicants to make the fin

24 June 2019 / MedTech Innovator Leading Startup Awarded $25,000 Global Prize for its Intraoperative Handheld Imaging Tools to Identify and More Effectively Remove Tumor in Patients with Breast Cancer OncoRes CEO, Dr Kath Giles (front centre) receiving award. Excerpt from article: MedTech Innovator , the premier global nonprofit accelerator in the medical technology industry, today announced that OncoRes Medical , a medical device company developing an imaging tool to impro

Wednesday, 12 June 2019 Katherine Giles, OncoRes Medical at Pitch@Palace Australia 2.0 Australian start-up OncoRes was founded in 2016 to...

Thursday, 13 December 2018 / Briana Sherperd / ABC News The device can provide images of what could previously only be felt. (Supplied) Excerpt from article: Perth-based technology start-up OncoRes Medical has been internationally recognised for its work in attempting to improve the outcome of breast cancer surgery. The WA company was announced as one of three winners at the London-held finals of Pitch@Palace — a competition that identifies emerging start-ups from around

Wednesday, 7 November 2018 The finalists of the 2018 program were showcased at the ceremony using videos of their innovations. Emerging Innovation Category Finalist: OncoRes Medical - MRprobe - An Intraoperative Medical Imaging Device OncoRes Medical provides surgeons with a high resolution, handheld imaging probe to dramatically increase surgical accuracy and effectively remove tumour during surgery. The technology can substantially improve patient outcomes in breast-conserv

Tuesday, 12 Jun 2018 / By Prof. Peter Leedman / Business News Delivering research from the bench to the bedside. Excerpt from article: Australia’s medical technology, biotechnology and pharmaceutical sector is showing encouraging signs for future investors. According to the latest report by the Australian government’s MedTech and Pharma Growth Centre, MTPConnect, exports from the sector grew 30% to $5.2 billion in 2016. MTPConnect’s report also highlights growth in the wi

Thursday, 8 March 2018 / University of Western Australia Except from article: Katharine Giles - UWA graduate Winner of a 40under40 Award Katharine Giles is investment manager at Brandon Capital, a venture capital firm devoted to supporting Australian life sciences businesses. She has worked on funding deals for biomedical science businesses including OncoRes Medical, a business developing a probe to improve breast cancer treatments. Dr Giles is interim chief executive of On

Tuesday, 22 August 2017 / University of Western Australia Excerpt from article: The Faculty of Engineering and Mathematical Sciences’ (EMS) Senior Research Fellow, Dr Brendan Kennedy, leads the cross-disciplinary research team behind the newly established Perth Company, OncoRes Medical. The company has recently secured up to $6 million of funding to commercialise a surgical tool, developed by Dr Kennedy’s team of researchers at the Harry Perkins Institute of Medical Researc

Friday, 2 Jun 2017 / By Mark Beyer / Business News (L-R) Kath Giles, Liza Dunne, Christobel Saunders and Brendan Kennedy at today's announcement. Photo: Attila Csaszar Except from article: Newly established Perth company OncoRes Medical has secured up to $6 million of funding to commercialise a surgical tool developed by researchers at the Harry Perskins Institute of Medical Research and the University of Western Australia. This article was first published by Business New